Candida: Difference between revisions
From IDWiki
Candida
(→: added links) |
m (→) |
||
Line 15: | Line 15: | ||
* ''[[C. auris]]'' |
* ''[[C. auris]]'' |
||
= Clinical Presentation = |
|||
= Infections = |
|||
* Most common: mouth, vagina, skin |
* Most common: mouth, vagina, skin |
Revision as of 20:05, 13 August 2019
- Most common medically-important genus of yeast
Microbiology
- Budding yeast
Organisms
- C. albicans
- C. dubliniensis
- C. glabrata: Fluconazole-resistant
- C. tropicalis
- C. parapsilosis
- C. krusei
- C. auris
Clinical Presentation
- Most common: mouth, vagina, skin
- In immunocompromised, ICU, IVDU, or TPN patients: Esophagus, blood, CNS, endophthalmitis
- Less common: joint
- IVDU: endocarditis
Investigations
- Urine culture if concern for cystitis
- Blood culture
- Never ignore candidemia!
- Requires an ophthalmology consult to rule out endophthalmitis (1-3% of cases)
- Echocardiogram if IVDU or prosthetic valve
- Germ tube test (GTT)
- If positive, indicates C. albicans or C. dubliniensis
- Identifies fluconazole-sensitive Candidae
Species and Resistance
Species | Resistance pattern |
---|---|
C. albicans | Generally fluconazole-susceptible |
C. dubliniensis | Generally fluconazole-susceptible |
C. parapsilosis | Generally fluconazole-susceptible |
C. glabrata | Often fluconazole resistant, or dose-dependent |
C. tropicalis | Generally fluconazole-susceptible |
C. krusei | Inherent fluconazole resistance |
C. lusitaniae | Often amphotericin resistant but fluconazole-susceptible |
Treatment
- First-line:
- Remove lines!
- GGT positive: fluconazole for 2 weeks after first negative blood culture
- GGT negative: move to second-line therapies
- Second-line: micafungin, then amphotericin B (last choice)
- Endophthalmitis: extend course to 4 weeks
- Failure of therapy: double-check for endophthalmitis